Evidence map›Paper›PMID 23594387›Full record

ReviewLancet (London, England)2013

The changing epidemiology of malaria elimination: new strategies for new challenges.

Chris Cotter, Hugh J W Sturrock, Michelle S Hsiang, Jenny Liu, Allison A Phillips, Jimee Hwang, Cara Smith Gueye, Nancy Fullman, Roly D Gosling, Richard G A Feachem

Erratum issued 3 registry-linked trialsAbstract readReview
PubMed Full text at PMC Publisher
In one paragraph

Review in Lancet (London, England), 2013. The graph could read no effect estimate from its abstract, so it casts no vote on the map. An erratum has been issued. It is linked to 3 registered trials, which are not on this map. Cited by 418 papers, 8 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
418citing papers in PubMed, 8 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT03783299 phase4completednot on this mapstarted 2017, after this paper: background citation

Assessing the Effectiveness of Targeted Active Case Detection Among High Risk Populations in Southern Lao PDR

TypeinterventionalSponsorUniversity of California, San FranciscoRan2017 to 2018Enrolled39,968ConditionsPlasmodium Falciparum MalariaArmsStandard RDT and HS-RDT, Artemether-lumefantrine, Primaquine Phosphate
NCT04416945 nawithdrawnnot on this mapstarted 2020, after this paper: background citation

Targeting High-risk Populations With Enhanced Reactive Case Detection: a Study to Assess the Effectiveness and Feasibility for Reducing Plasmodium Falciparum and P. Vivax Malaria in Southern Lao Peoples Democratic Republic

TypeinterventionalSponsorUniversity of California, San FranciscoRan2020 to 2021Enrolled0ConditionsPlasmodium Falciparum Malaria, Plasmodium Vivax MalariaArmsHousehold Reactive Case Detection, RACD of cases' co-workers/co-travelers, Case Management and Follow-up
NCT05052502 nacompletednot on this mapstarted 2020, after this paper: background citation

Targeting High-risk Populations With Enhanced Reactive Focal Mass Drug Administration: A Study to Assess the Effectiveness and Feasibility for Plasmodium Falciparum and Plasmodium Vivax Malaria in Thailand

TypeinterventionalSponsorUniversity of California, San FranciscoRan2020 to 2022Enrolled14,977ConditionsPlasmodium Falciparum Malaria, Plasmodium Vivax MalariaArmsCase Management and Follow-up, Reactive focal mass drug administration (rfMDA)
3 · Its place in the literature

Who cites it

418 citing papers in PubMed, 8 syntheses or guidelines pooled it.

  1. Pooled it
  2. Pooled it
  3. Pooled it
  4. Pooled it
  5. Pooled it
  6. Pooled it
  7. Global patterns of submicroscopicThe Lancet. Microbe · 2021
    Pooled it
  8. Pooled it
  9. Trial
  10. Trial
  11. Trial
  12. Trial
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article

358 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

10 authors.

Chris CotterThe Global Health Group, University of California, San Francisco, CA 94105, USA. cotterc@globalhealth.ucsf.edu
Hugh J W Sturrock
Michelle S Hsiang
Jenny Liu
Allison A Phillips
Jimee Hwang
Cara Smith Gueye
Nancy Fullman
Roly D Gosling
Richard G A Feachem

Funding

Intramural CDC HHS CC999999
6 · The paper itself

Abstract

Malaria-eliminating countries achieved remarkable success in reducing their malaria burdens between 2000 and 2010. As a result, the epidemiology of malaria in these settings has become more complex. Malaria is increasingly imported, caused by Plasmodium vivax in settings outside sub-Saharan Africa, and clustered in small geographical areas or clustered demographically into subpopulations, which are often predominantly adult men, with shared social, behavioural, and geographical risk characteristics. The shift in the populations most at risk of malaria raises important questions for malaria-eliminating countries, since traditional control interventions are likely to be less effective. Approaches to elimination need to be aligned with these changes through the development and adoption of novel strategies and methods. Knowledge of the changing epidemiological trends of malaria in the eliminating countries will ensure improved targeting of interventions to continue to shrink the malaria map.

Indexed as

CivilizationDeveloping CountriesAdolescentAdultAfrica South of the SaharaAgedCluster AnalysisCross-Sectional StudiesEmigration and ImmigrationFemaleHumansMalariaMalaria, FalciparumMalaria, VivaxMaleMiddle Aged

Identifiers

PMID23594387
PMCPMC10583787

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.